143 related articles for article (PubMed ID: 37306807)
21. Pancreas Involvement of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Presenting as Acute Pancreatitis: A Case Report.
Lee DW; Kim YJ; Cho CM
Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 35893106
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.
Huang H; Lin Z; Lin X; Cai Q; Xia Z; Jiang W
Leuk Lymphoma; 2011 Jun; 52(6):1041-8. PubMed ID: 21599590
[TBL] [Abstract][Full Text] [Related]
23. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
[TBL] [Abstract][Full Text] [Related]
24. [Airway obstruction due to localized tracheal lesion of extranodal NK/T-cell lymphoma, nasal type].
Takahashi H; Ohkawara H; Shichishima-Nakamura A; Fukatsu M; Sano T; Harada-Shirado K; Kimura S; Togawa R; Tasaki K; Hashimoto Y; Ogawa K; Ikezoe T
Rinsho Ketsueki; 2018; 59(8):1012-1015. PubMed ID: 30185700
[TBL] [Abstract][Full Text] [Related]
25. Case Report: Primary NK/T Cell Lymphoma Nasal Type of the Colon With Multiple Intestinal Perforations.
Zhang Y; Liu W; Zhang X; Wu B
Front Oncol; 2021; 11():577939. PubMed ID: 33816224
[No Abstract] [Full Text] [Related]
26. A case report of primary cutaneous natural killer/T-cell lymphoma.
Tian C; Yu Y; Zhang Y
Mol Clin Oncol; 2016 Dec; 5(6):777-778. PubMed ID: 28101356
[TBL] [Abstract][Full Text] [Related]
27. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
Nomura M; Sumiya R; Ono H; Nagai T; Kumazawa K; Shimizu A; Endo D; Aoyanagi N
World J Surg Oncol; 2021 Jan; 19(1):4. PubMed ID: 33388058
[TBL] [Abstract][Full Text] [Related]
28. Intestinal perforation secondary to intestinal Burkitt lymphoma.
Takayama Y; Saito M; Ichida K; Muto Y; Tanaka A; Rikiyama T
Int J Surg Case Rep; 2021 Feb; 79():417-420. PubMed ID: 33524798
[TBL] [Abstract][Full Text] [Related]
29. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
[TBL] [Abstract][Full Text] [Related]
30. Current and future management of NK/T-cell lymphoma based on clinical trials.
Yamaguchi M
Int J Hematol; 2012 Nov; 96(5):562-71. PubMed ID: 23073619
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients.
Zhou Z; Li X; Chen C; Li X; Zhang L; Li L; Wang X; Ma W; Fu X; Wu J; Sun Z; Zhang X; Li Z; Yan J; Chang Y; Lu L; Qin B; Li X; Wen J; Zhang M
Ann Hematol; 2014 Nov; 93(11):1889-94. PubMed ID: 24923454
[TBL] [Abstract][Full Text] [Related]
32. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
[TBL] [Abstract][Full Text] [Related]
34. Extra nodal NK/T-cell lymphoma nasal type that responded to DeVIC combination chemotherapy.
Nomura E; Isoda K; Yamanaka K; Yamaguchi M; Hakamada A; Mizutani H
J Dermatol; 2005 Mar; 32(3):204-9. PubMed ID: 15863868
[TBL] [Abstract][Full Text] [Related]
35. A case report of an extranodal NK/T-cell lymphoma nasal type, occurring primarily in eyes with masquerade syndrome.
Zhang F; Duan X; Liu K
Medicine (Baltimore); 2019 Mar; 98(11):e14836. PubMed ID: 30882672
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of advanced extranodal NK/T cell lymphoma with unrelated cord blood transplantation.
Yokoyama H; Yamada MF; Ishizawa K; Yamamoto J; Tomiya Y; Harigae H; Kameoka J; Ichinohasama R; Sasaki T
Tohoku J Exp Med; 2007 Apr; 211(4):395-9. PubMed ID: 17409680
[TBL] [Abstract][Full Text] [Related]
37. Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study.
Wei C; Cao X; Zhang W; Zhang Y; Wang W; Zhang L; Yang C; Feng J; Cai H; Chen M; Mao Y; Zhou D
Ann Hematol; 2020 Dec; 99(12):2801-2809. PubMed ID: 32399707
[TBL] [Abstract][Full Text] [Related]
38. Primary colon natural killer (NK)/T-cell lymphoma, nasal type, with perforations: a case report and literature review.
Xie Y; Liu Y; Wen C; Li W; Lu X; Deng L
Ann Palliat Med; 2021 Nov; 10(11):12025-12033. PubMed ID: 34872326
[TBL] [Abstract][Full Text] [Related]
39. Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma.
Nagai S; Hiraga J; Suzuki N; Suzuki N; Takagi Y; Narita M; Kagami Y
Case Rep Hematol; 2018; 2018():1583925. PubMed ID: 30515337
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal Diffuse Large B-cell Lymphoma.
Tanaka H; Mori E; Akutsu T; Saito S; Tei M; Otori N
Clin Med Insights Oncol; 2023; 17():11795549231156692. PubMed ID: 36908718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
